Integral Ad Science (NASDAQ:IAS) CEO Sells $175,950.73 in Stock

Key Points

• Integral Ad Science CEO Lisa Utzschneider sold 17,267 shares for $175,950.73, reducing her ownership by 3.99%.
• The company's stock is currently trading at $10.19, with a market capitalization of $1.69 billion and a P/E ratio of 29.97.
• Analysts have given a mixed outlook, with one Buy rating and fourteen Hold ratings, averaging a target price of $12.81 for the stock.

Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) CEO Lisa Utzschneider sold 17,267 shares of Integral Ad Science stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $10.19, for a total value of $175,950.73. Following the completion of the transaction, the chief executive officer owned 415,293 shares of the company's stock, valued at $4,231,835.67. This trade represents a 3.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Lisa Utzschneider also recently made the following trade(s):

• On Wednesday, August 6th, Lisa Utzschneider sold 9,922 shares of Integral Ad Science stock. The stock was sold at an average price of $8.12, for a total value of $80,566.64.
• On Thursday, July 10th, Lisa Utzschneider sold 8,285 shares of Integral Ad Science stock. The stock was sold at an average price of $8.29, for a total value of $68,682.65.

Integral Ad Science Price Performance

NASDAQ:IAS traded down $0.01 during mid-day trading on Tuesday, reaching $10.19. The stock had a trading volume of 8,027,251 shares, compared to its average volume of 6,408,295. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of 29.97, a price-to-earnings-growth ratio of 1.45 and a beta of 1.60. Integral Ad Science Holding Corp. has a 1-year low of $6.26 and a 1-year high of $13.62. The stock's 50 day simple moving average is $8.97 and its two-hundred day simple moving average is $8.22.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. The firm had revenue of $149.20 million for the quarter, compared to analysts' expectations of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Sell-side analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on IAS. Robert W. Baird raised their target price on shares of Integral Ad Science from $9.00 to $10.30 and gave the stock a "neutral" rating in a report on Thursday, September 25th. BMO Capital Markets set a $10.30 price target on Integral Ad Science and gave the company a "market perform" rating in a report on Wednesday, September 24th. Truist Financial cut Integral Ad Science from a "strong-buy" rating to a "hold" rating in a report on Wednesday, September 24th. Barclays lifted their price target on Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a report on Friday, August 8th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Integral Ad Science in a report on Saturday, September 27th. One investment analyst has rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $12.81.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in IAS. Corvex Management LP purchased a new position in Integral Ad Science during the 1st quarter worth approximately $21,101,000. Nuveen LLC acquired a new stake in shares of Integral Ad Science during the 1st quarter valued at $10,897,000. Alta Fox Capital Management LLC boosted its stake in shares of Integral Ad Science by 20,831.9% during the 1st quarter. Alta Fox Capital Management LLC now owns 1,214,053 shares of the company's stock valued at $9,785,000 after buying an additional 1,208,253 shares during the period. Ameriprise Financial Inc. boosted its stake in shares of Integral Ad Science by 1,195.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,254,049 shares of the company's stock valued at $10,421,000 after buying an additional 1,157,220 shares during the period. Finally, CenterBook Partners LP boosted its stake in shares of Integral Ad Science by 163.3% during the 2nd quarter. CenterBook Partners LP now owns 1,716,602 shares of the company's stock valued at $14,265,000 after buying an additional 1,064,722 shares during the period. Institutional investors and hedge funds own 95.78% of the company's stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.